With 21.5 million shares changed hands, the volume of the stock remained heavier than its average volume of 3.54 million shares. During the session, the Specialty Chemicals company that operates in wider Basic Materials sector, reached to the highest price of $2.4099 whereas the lowest price it dropped to was $1.93. The 52-week range on BON shows that it touched its highest point at $73.75 and its lowest point at $1.14 during that stretch. Beta for the stock currently stands at -0.47.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BON was up-trending over the past week, with a rise of 16.67%, but this was up by 50.19% over a month. Three-month performance dropped to -91.19% while six-month performance fell -95.10%. The stock lost -97.15% in the past year, while it has lost -95.57% so far this year.
Float and Shares Shorts:
At present, 0.16 million BON shares are outstanding with a float of 0.04 million shares on hand for trading. On 2025-05-15, short shares totaled 77859.0, which was 206.99999999999997 higher than short shares on 1744675200. In addition to Mr. Yongwei Hu as the firm’s Chairman & CEO, Mr. Wang L. Lee serves as its Chief Financial Officer.
Institutional Ownership:
Through their ownership of 0.01594 of BON’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $145 being high and $145 being low. For BON, this leads to a yearly average estimate of $145. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.
